Advertisement
Screener

Quoin Pharmaceuticals Ltd. (QNRX) Proceeds From Current Borrowings

2.8 / 5 stars · 68/120 Roast Me

Quoin Pharmaceuticals Ltd. Proceeds From Current Borrowings

Quoin Pharmaceuticals Ltd. (QNRX) reported Proceeds From Current Borrowings of ILS 110.00 thousand for the 0-month period ending 2021-04-13, per its 6-K filed 2021-08-24.

Discontinued › Cash Flow › Financing Activities

ifrs-full:ProceedsFromCurrentBorrowings · last filed 2021-08-24

  • 2021-04-13: Proceeds From Current Borrowings 0 month 110.00K ILS.
  • 2020-05-12: Proceeds From Current Borrowings 0 month 5.20M ILS.
  • 2020-01-07: Proceeds From Current Borrowings 0 month 10.41M ILS.
  • 2018-01-31: Proceeds From Current Borrowings 1 month 13.62M ILS.
Period endProceeds From Current Borrowings 0 monthProceeds From Current Borrowings 1 month
2021-04-13110.00K ILS
6-K · filed 2021-08-24
2020-05-125.20M ILS
20-F · filed 2021-03-29
2020-01-0710.41M ILS
20-F · filed 2021-03-29
2018-01-3113.62M ILS
20-F · filed 2019-03-18
2017-09-0715.21M ILS
20-F · filed 2019-03-18
2016-07-2832.11M ILS
20-F · filed 2019-03-18
32.11M ILS
20-F · filed 2020-04-03

Similar stocks

Stock NameCountryMarket CapPE Ratio
CYPHERPUNK TECHNOLOGIES INC. (CYPH)United States$0.438B-75.63
PROTHENA CORP PUBLIC LTD CO (PRTA)Ireland$0.428B-11.53
MapLight Therapeutics, Inc. (MPLT)United States$0.459B-7.10
DiaMedica Therapeutics Inc. (DMAC)United States$0.423B-10.11
Atea Pharmaceuticals, Inc. (AVIR)United States$0.414B-2.26
ARS Pharmaceuticals, Inc. (SPRY)United States$0.414B-3.70
RELMADA THERAPEUTICS, INC. (RLMD)United States$0.406B-11.92
Opus Genetics, Inc. (IRD)United States$0.406B-3.16
ASSEMBLY BIOSCIENCES, INC. (ASMB)United States$0.481B-13,053.96
Arcturus Therapeutics Holdings Inc. (ARCT)$0.402B-2.05